Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A lot more buying opportunity on deck. I have been 100% correct so far.
Bids for puts are up significantly. Not a favorable outlook today.
Volume drying up already. $1’s on deck
This trash finished in the red despite the noise
HGEN going to $1
Just wait HGEN will be lower very soon.
HGEN is not a good covid play.
Don’t count your many too fast? We can short it right back before the close.
Wrong.
Like I said yesterday above $4 is a breakout. I think we make a new 52 week high today! Time to break $10 is here! $HGEN #Lenzilumab #CytokineStorm [Suppressed Image]
I think $2,s under $5.
Your statement SP would never be under $5.
Wrong.
Looks like half that $4.90 is gone. $1’s on deck.
But but JPMorgan ...HGEN looks like it’s filling the gap between $1 to $2.50. Toast
You are on your game. “A” game at that.
I agree. Both. The board is made up of incompetent individuals because they have not fired him.
Missling prays upon the weak.
Anavex should be at the top of this list. Scamavex
Missling is a habitual liar.
I’m not in CYDY. It can go to negative zero. I made over 300% on that one. Number one rule of trading. Do not make a trade a long position. Date these stocks on momentum.
Didn’t they have a reverse split previously? This is like burning money in a 55 gallon drum. Lol.
CEO sucks.
Scooter, good summary. I bet these retail gamblers wished they would have sold when you informed them. It’s looking like a dollar is in view at the rate this baby is bleeding. Company received money from jumping on the covid ban wagon but it’s clearly not a covid play.
Martin appears to be advising them.
I see this trash continues to drip down. Mild/moderate covid and one person died in a mild/moderate trial. That’s a recipe for failure.
Is this garbage still trading? Folks still waiting for Misleading the CEO of Anavex to release results at mid year?
A covid competitor. CEO gave warning to shorts. Making $.
https://mobile.twitter.com/RagingBull/status/1298369002872410112
No volume. Looking At 2’s. Again.
Humanigen in low 3’s. This stock sucks.
Stock Still trash. Anavex sucks.
When the charts turn here I will buy some shares just to rub it in. MACD is ugly. CMF , RSI is getting there.
Ashes to Ashes. $2’s now. Throat getting tighter now.
$10 in June. 2030. Lol.
12 or so people and one died and all the bragging. Get results and ring me. Good luck with that.
Throat getting tight? Brag about your share count will you.
Ashes to Ashes. Low’s $3’s and counting.
But but JPM. Lol.
It’s about the product.
Ashes to ashes...Back in the $4’s and low $4’s. But but but JPMORGAN my ashes.
NIH is littered with funded study failures $ does not mean success.
Volume is a one trick anchor. On the other end is the titanic. HGEN lol.
Volume suggest - watch out below. HGEN balloon popped at $6.79 and it has the potential to get down to the 50 day.
I did and stock dropping like i suggested
Trial exclusion is reason not to trust company or results.
“Any condition that, in the opinion of the investigator, is likely to interfere with the safety and efficacy “
This is that company running a bogus trial. No ARDS patients allowed and they want to be a treatment. Don’t get Covid because they are basically saying they can’t help.
Trial exclusion.
Exclusion Criteria:
Confirmed diagnosis of ARDS
Confirmed diagnosis of bacterial pneumonia or other active/uncontrolled fungal or viral infections at screening/baseline
Known medical history of tuberculosis or a risk for tuberculosis exposure
Known history of hepatitis A, hepatitis B, hepatitis C or HIV infection
History of pulmonary alveolar proteinosis (PAP)
Requiring invasive mechanical ventilation upon hospitalization prior to randomization
Women of childbearing potential who are pregnant or breastfeeding
Known hypersensitivity to lenzilumab or any of its components
Use of anti-IL-6 therapy or any other potent immunomodulatory or immunosuppressive therapy or live vaccine within 8 weeks of randomization (corticosteroid use is permitted)
Use of GM-CSF agents (e.g., sargramostim) within prior 2 months of randomization
Expected survival < 24h in the opinion of the investigator
Patient > 85 years of age
Any condition that, in the opinion of the investigator, is likely to interfere with the safety and efficacy of the study treatment or puts the patient at unacceptably
HGEN is still garbage.
I’m going to buy a few more on a PSAR. I have over $100k sitting in cash.